Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

TAKEDA PHARMACEUTICAL CO LTD (TAK)

  • Business News
  • Aug. 17, 2026, 12:23 UTC
  • 3
  • 1 comments

Clinical trial NCT06254950 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. primary completion date: 2026-09-30 → 2026-07-14 3. enrollment: 207 → 213 participants 4. enrollment type: ESTIMATED → ACTUAL

Market reaction Comment Full text

ARCUS BIOSCIENCES, INC. (RCUS)

  • Business News
  • Aug. 17, 2026, 12:23 UTC
  • 4
  • 1 comments

Clinical trial NCT06048133: primary completion date: 2026-07-01 → 2026-12-01.

Market reaction Comment Full text

VERADERMICS, INC (MANE)

  • Business News
  • Aug. 17, 2026, 12:23 UTC
  • 4
  • 1 comments

Clinical trial NCT07146022: status: RECRUITING → ACTIVE_NOT_RECRUITING.

Market reaction Comment Full text

MEDTRONIC PLC (MDT)

  • Business News
  • Aug. 17, 2026, 12:23 UTC
  • 3
  • 1 comments

Clinical trial NCT05198674: primary completion date: 2026-11-30 → 2026-03-05.

Market reaction Comment Full text

GSK PLC (GSK)

  • Business News
  • Aug. 17, 2026, 12:23 UTC
  • 1
  • 1 comments

Clinical trial NCT07285239 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-07-01 → 2026-09-01

Market reaction Comment Full text

ASTRAZENECA PLC (AZN)

  • Business News
  • Aug. 17, 2026, 12:23 UTC
  • 1
  • 1 comments

Clinical trial NCT05850234 updates: 1. completion date: 2028-11-14 → 2029-01-25 2. primary completion date: 2027-08-31 → 2027-10-01 3. enrollment: 182 → 232 participants

Market reaction Comment Full text

BRISTOL MYERS SQUIBB CO (BMY)

  • Business News
  • Aug. 17, 2026, 12:23 UTC
  • 1
  • 1 comments

Clinical trial NCT07063342: enrollment: 72 → 236 participants.

Market reaction Comment Full text

THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. (TSOI)

  • Business News
  • Aug. 17, 2026, 12:23 UTC
  • 1
  • 1 comments

Clinical trial NCT07570862 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-07-01 → 2026-07-27

Market reaction Comment Full text

ASTRAZENECA PLC (AZN)

  • Business News
  • Aug. 17, 2026, 12:23 UTC
  • 1
  • 1 comments

Clinical trial NCT04862663 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 895 → 893 participants 3. enrollment type: ESTIMATED → ACTUAL

Market reaction Comment Full text

ALMIRALL SA (ALMRY)

  • Business News
  • Aug. 17, 2026, 12:23 UTC
  • 0
  • 1 comments

Clinical trial NCT07542483 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-04-01 → 2026-04-24

Market reaction Comment Full text

DEXCOM INC (DXCM)

  • Business News
  • Aug. 17, 2026, 12:23 UTC
  • 0
  • 1 comments

Clinical trial NCT06939413 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2026-10-01 → 2026-11-01 3. primary completion date: 2026-10-01 → 2026-11-01

Market reaction Comment Full text

GSK PLC (GSK)

  • Business News
  • Aug. 17, 2026, 12:23 UTC
  • 0
  • 1 comments

Clinical trial NCT07456033 updates: 1. completion date: 2030-07-08 → 2030-09-23 2. primary completion date: 2030-07-08 → 2030-09-23

Market reaction Comment Full text

BOSTON SCIENTIFIC CORPORATION

  • Business News
  • Aug. 17, 2026, 12:23 UTC
  • 0
  • 1 comments

Clinical trial NCT05825820 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-07-01 → 2026-07-31 3. completion date: 2026-10-01 → 2027-02-01 4. primary completion date: 2026-10-01 → 2027-01-01

Market reaction Comment Full text

ELI LILLY & CO (LLY)

  • Business News
  • Aug. 17, 2026, 12:23 UTC
  • 0
  • 1 comments

Clinical trial NCT07686757 updates: 1. status: NOT_YET_RECRUITING → ENROLLING_BY_INVITATION 2. start date: 2026-09-01 → 2026-08-12

Market reaction Comment Full text

SWEDISH ORPHAN BIOVITRUM AB (SWOBY)

  • Business News
  • Aug. 17, 2026, 12:23 UTC
  • 0
  • 1 comments

Clinical trial NCT07719647 updates: 1. start date: 2026-09-01 → 2027-02-01 2. completion date: 2027-09-01 → 2028-02-01 3. primary completion date: 2027-09-01 → 2028-02-01

Market reaction Comment Full text
  • Previous
  • 570
  • 571
  • 572
  • 573
  • 574
  • Next

Search

News categories

  • Technical Exchange News(14412)
  • Event(6229)
  • SEC News(376721)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(230482)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin